Clinical Trial Update: Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors [NA]

View source ↗

Summary

The document reports that a study evaluating an EpCAM-targeted radiotracer in malignant epithelial tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Epithelial Tumors, Malignant | NA | Status: RECRUITING